Literature DB >> 9460034

Risperidone in the management of violent, treatment-resistant schizophrenics hospitalized in a maximum security forensic facility.

N C Beck1, S R Greenfield, H Gotham, A A Menditto, P Stuve, C A Hemme.   

Abstract

This study examines the effectiveness of risperidone compared with traditional neuroleptic medications in the areas of clinical functioning and aggressive behaviors in a sample of inpatients diagnosed with chronic schizophrenia. Similar to the methodology of Menditto et al. (Psychiatr Serv 47:46-51, 1996), two groups of 10 patients were selected from those being treated in a comprehensive psychosocial rehabilitation program. Group 1 subjects were placed on risperidone at various times during their treatment. Group 2 subjects, who were matched with Group 1 subjects on pre-study levels of clinical functioning as measured by the Time-Sample Behavioral Checklist (TSBC), remained on traditional neuroleptics throughout the study period. For each subject, scores on six TSBC subscales were examined at four time points; data were analyzed with repeated-measures multivariate analyses of variance and univariate analyses of variance. Frequency counts of aggressive behaviors (threats and assaults) were compiled into two six-month time periods and analyzed with nonparametric techniques. The risperidone group did not differ from the traditional neuroleptic group on measures of clinical functioning and aggressiveness measured over time. Both groups evidenced improvements in bizarre motor behaviors over the study period. The risperidone group evidenced some deterioration in measures of appropriate interpersonal interaction over time. No differences in aggressive behaviors were noted for either group. The study concludes that for forensic patients with chronic schizophrenia, risperidone failed to produce therapeutic effects in overall clinical functioning and aggressive behaviors that were significantly different from traditional neuroleptics. Descriptive comparisons are made between the receptor-binding profiles and clinical effectiveness of risperidone and clozapine in an attempt to explain these findings.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9460034

Source DB:  PubMed          Journal:  J Am Acad Psychiatry Law        ISSN: 1093-6793


  4 in total

1.  Organisational interventions for preventing and minimising aggression directed towards healthcare workers by patients and patient advocates.

Authors:  Evelien Spelten; Brodie Thomas; Peter F O'Meara; Brian J Maguire; Deirdre FitzGerald; Stephen J Begg
Journal:  Cochrane Database Syst Rev       Date:  2020-04-29

2.  The Prevalence and Factors Associated With Antipsychotic Polypharmacy in a Forensic Psychiatric Sample.

Authors:  Christian Farrell; Johann Brink
Journal:  Front Psychiatry       Date:  2020-04-17       Impact factor: 4.157

3.  Pharmacological Treatment in Forensic Psychiatry-A Systematic Review.

Authors:  Katarina Howner; Peter Andiné; Göran Engberg; Emin Hoxha Ekström; Eva Lindström; Mikael Nilsson; Susanna Radovic; Monica Hultcrantz
Journal:  Front Psychiatry       Date:  2020-01-16       Impact factor: 4.157

Review 4.  Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).

Authors:  Edoardo G Ostinelli; Mohsin Hussein; Uzair Ahmed; Faiz-Ur Rehman; Krista Miramontes; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2018-04-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.